Ron Finklestien
Biogen’s Underwhelming Q4 Performance Signals Stormy Weather Ahead
Q4 Earnings: A Bumpy Road Biogen (BIIB) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, distinctly missing the Zacks Consensus Estimate of ...
Stocks Tumble as Coca-Cola Posts Strong Sales
Stocks Tumble as Coca-Cola Posts Strong Sales
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Tuesday. The Dow traded down 1.05% to 38,389.76 while ...
Assessing Bitcoin’s Fundamentals
The Ever-Evolving Metrics of Bitcoin
Are you investing in bitcoin (BTC-USD) or companies related to the Bitcoin network? It’s crucial to have a set of metrics for evaluating the ...
Financial Losers: Analyzing Brighthouse Financial, Greenidge Generation, and Argo Blockchain
Financial Losers: Analyzing Brighthouse Financial, Greenidge Generation, and Argo Blockchain
champc Gainers: Solowin Holdings (SWIN) +12%. Prestige Wealth (PWM) +10%. Crawford & Co. (CRD-A) +6%. Losers: Bit Brother (BETS) -19%.
Investors Eyeing Best Momentum Stocks for February 13th
On February 13, investors are presented with a trio of stocks demonstrating both strong momentum and a buy rank. Equitrans Midstream Corporation Equitrans Midstream ...
ResMed (RMD) Innovates With AirCurve 11 for Sleep Apnea Treatment
ResMed (RMD) Innovates With AirCurve 11 for Sleep Apnea Treatment
ResMed, Inc. RMD has unveiled its AirCurve 11 series devices, the latest bilevel devices utilizing two levels of support – inspiratory positive airway pressure ...
US Stocks Drop Over 300 Points Amid Falling Market
Market Opening Performance This morning witnessed a descent in U.S. stocks, with the Dow Jones index plummeting over 300 points on Tuesday. The Dow ...
Mad Money Lightning Round: Jim Cramer’s Stock Recommendations
Jim Cramer’s Stock Picks and Analysis
Among the myriad of stock recommendations from the renowned Jim Cramer on CNBC’s “Mad Money Lightning Round,” he hailed Vertiv Holdings Co VRT as ...
Gilead to Acquire CBAY: Transformational Move for GILD
Gilead to Acquire CBAY: A Striking Opportunity for GILD
Gilead Sciences, Inc. GILD has made a substantial move in its business strategy with the announcement of acquiring CymaBay Therapeutics, Inc. CBAY, for a ...
Ecolab’s Triumph and Other Big Stocks Moving Higher on Tuesday
Ecolab’s Triumph and Other Big Stocks Moving Higher on Tuesday
February 13, 2024 10:09 AM | 2 min read U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on ...
